Search Results - "Diabetes therapy"

Refine Results
  1. 1

    Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial by Haak, Thomas, Hanaire, Hélène, Ajjan, Ramzi, Hermanns, Norbert, Riveline, Jean-Pierre, Rayman, Gerry

    Published in Diabetes therapy (01-02-2017)
    “…Introduction Glycemic control in participants with insulin-treated diabetes remains challenging. We assessed safety and efficacy of new flash glucose-sensing…”
    Get full text
    Journal Article
  2. 2

    The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials by Min, Thinzar, Bain, Stephen C.

    Published in Diabetes therapy (01-01-2021)
    “…Glucagon-like peptide 1 (GLP-1) based therapy is an established treatment option for the management of type 2 diabetes mellitus (T2DM) and is recommended early…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A Practical Review of C-Peptide Testing in Diabetes by Leighton, Emma, Sainsbury, Christopher AR, Jones, Gregory C.

    Published in Diabetes therapy (01-06-2017)
    “…C-peptide is a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more…”
    Get full text
    Journal Article
  5. 5

    Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy by Bonora, Benedetta Maria, Boscari, Federico, Avogaro, Angelo, Bruttomesso, Daniela, Fadini, Gian Paolo

    Published in Diabetes therapy (01-06-2020)
    “…Introduction In late February 2020, due to the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the Italian Government closed down all…”
    Get full text
    Journal Article
  6. 6

    Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy by Bonora, Benedetta Maria, Boscari, Federico, Avogaro, Angelo, Bruttomesso, Daniela, Fadini, Gian Paolo

    Published in Diabetes therapy (01-06-2020)
    “…In late February 2020, due to the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the Italian Government closed down all educational…”
    Get full text
    Journal Article
  7. 7

    Drug Therapy in Obesity: A Review of Current and Emerging Treatments by Williams, David M., Nawaz, Asif, Evans, Marc

    Published in Diabetes therapy (01-06-2020)
    “…Whilst the prevalence of obesity continues to increase at an alarming rate worldwide, the personal and economic burden of obesity-related complications becomes…”
    Get full text
    Journal Article
  8. 8

    The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies by Evans, Mark, Welsh, Zoë, Ells, Sara, Seibold, Alexander

    Published in Diabetes therapy (01-01-2020)
    “…Introduction Glycated haemoglobin A1c (HbA1c) is the established standard measurement for assessment of glycaemic control in people with diabetes. Here we…”
    Get full text
    Journal Article
  9. 9

    Diabetes Dyslipidemia by Schofield, Jonathan D., Liu, Yifen, Rao-Balakrishna, Prasanna, Malik, Rayaz A., Soran, Handrean

    Published in Diabetes therapy (01-06-2016)
    “…Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has…”
    Get full text
    Journal Article
  10. 10

    A View Beyond HbA1c: Role of Continuous Glucose Monitoring by Chehregosha, Haleh, Khamseh, Mohammad E., Malek, Mojtaba, Hosseinpanah, Farhad, Ismail-Beigi, Faramarz

    Published in Diabetes therapy (01-06-2019)
    “…Hemoglobin A1C (HbA1c) is used as an index of average blood glucose measurement over a period of months and is a mainstay of blood glucose monitoring. This…”
    Get full text
    Journal Article
  11. 11

    Adherence to Therapies in Patients with Type 2 Diabetes by García-Pérez, Luis-Emilio, Álvarez, María, Dilla, Tatiana, Gil-Guillén, Vicente, Orozco-Beltrán, Domingo

    Published in Diabetes therapy (01-12-2013)
    “…Adherence to therapy is defined as the extent to which a person’s behavior in taking medication, following a diet, and/or executing lifestyle changes,…”
    Get full text
    Journal Article
  12. 12

    Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas by Kesavadev, Jothydev, Saboo, Banshi, Krishna, Meera B., Krishnan, Gopika

    Published in Diabetes therapy (01-06-2020)
    “…The year 2021 will mark 100 years since the discovery of insulin. Insulin, the first medication to be discovered for diabetes, is still the safest and most…”
    Get full text
    Journal Article
  13. 13

    Treatment Options for MODY Patients: A Systematic Review of Literature by Delvecchio, Maurizio, Pastore, Carmela, Giordano, Paola

    Published in Diabetes therapy (01-08-2020)
    “…Maturity-onset diabetes of the young (MODY) is an unusual form of diabetes with specific features that distinguish it from type 1 and type 2 diabetes. There…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014 by Carls, Ginger, Huynh, Johnny, Tuttle, Edward, Yee, John, Edelman, Steven V.

    Published in Diabetes therapy (01-08-2017)
    “…Introduction Previous research has found that the percentage of US adults with diabetes achieving a glycated hemoglobin (HbA1c) target of <7.0% with currently…”
    Get full text
    Journal Article
  16. 16

    Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis by Uloko, Andrew E., Musa, Baba M., Ramalan, Mansur A., Gezawa, Ibrahim D., Puepet, Fabian H., Uloko, Ayekame T., Borodo, Musa M., Sada, Kabiru B.

    Published in Diabetes therapy (01-06-2018)
    “…Introduction There has been no nationwide health (diabetes) survey in Nigeria since 1992, when a diabetes mellitus (DM) prevalence of 2.2% was reported. We…”
    Get full text
    Journal Article
  17. 17

    Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes by Strain, W. David, Down, Su, Brown, Pam, Puttanna, Amar, Sinclair, Alan

    Published in Diabetes therapy (01-05-2021)
    “…Prognosis and appropriate treatment goals for older adults with diabetes vary greatly according to frailty. It is now recognised that changes may be needed to…”
    Get full text
    Journal Article
  18. 18

    Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology by Kalra, Sanjay

    Published in Diabetes therapy (01-12-2014)
    “…Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a newly developed class of oral anti-diabetic drugs (OADs) with a unique mechanism of action. This…”
    Get full text
    Journal Article
  19. 19

    Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes by Haak, Thomas, Hanaire, Hélène, Ajjan, Ramzi, Hermanns, Norbert, Riveline, Jean-Pierre, Rayman, Gerry

    Published in Diabetes therapy (01-06-2017)
    “…Introduction Published evaluations of sensor glucose monitoring use in insulin treated type 2 diabetes are limited. The aim of this study was to assess the…”
    Get full text
    Journal Article
  20. 20

    Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review by Janež, Andrej, Guja, Cristian, Mitrakou, Asimina, Lalic, Nebojsa, Tankova, Tsvetalina, Czupryniak, Leszek, Tabák, Adam G., Prazny, Martin, Martinka, Emil, Smircic-Duvnjak, Lea

    Published in Diabetes therapy (01-02-2020)
    “…Here, we review insulin management options and strategies in nonpregnant adult patients with type 1 diabetes mellitus (T1DM). Most patients with T1DM should…”
    Get full text
    Journal Article